Analyst firms · BofA Securities · ICLR

BofA Securities ICLR price target and rating history

ICON plc (ICLR) · Health Care

BofA Securities rates ICON plc (ICLR) Neutral with a $185 price target, as of its latest action on Oct 9, 2026. It has published 4 rating actions on ICLR since November 2022, including 2 upgrades and 2 downgrades. Across 9 firms with a ICLR price target in the last 12 months, the median target is $135. BofA Securities's $185 is 37% above that.

Current rating
Neutral
Price target
$185
Median target, all firms
$135
Actions on ICLR
4

BofA Securities price target on ICLR

$260$168$752023202420252026
BofA Securities price target on ICLR, each point a stated target, November 2022 to October 2026.

Every BofA Securities rating on ICLR

How other firms rate ICLR

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BofA SecuritiesNeutral$185Oct 9, 2026
UBSNeutral$195Sep 30, 2026
Truist SecuritiesBuy$207Jun 30, 2026
RBC Capital MarketsOutperform$185Jun 25, 2026
BMO Capital MarketsOutperform$130Mar 26, 2026
JefferiesBuy$135Feb 23, 2026
TD CowenBuy$120Feb 18, 2026
Rothschild & Co RedburnNeutral$100Feb 17, 2026
Leerink PartnersMarket Perform$105Feb 12, 2026

Questions about BofA Securities and ICLR

What is BofA Securities's price target for ICLR?
BofA Securities's latest stated price target for ICON plc (ICLR) is $185, from its action on Oct 9, 2026.
What is BofA Securities's rating on ICLR?
BofA Securities rates ICLR Neutral, a neutral rating, as of Oct 9, 2026.
When did BofA Securities last change its view on ICLR?
On Oct 9, 2026, BofA Securities upgrades to Neutral from Underperform, price target $185.
How does BofA Securities's ICLR target compare with other analysts?
Across 9 firms with a ICLR price target in the last 12 months, the median target is $135. BofA Securities's $185 is 37% above that.

More ICLR rating histories

All BofA Securities ratingsICLR news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.